본문 바로가기
KERD
논문KCI 등재

The Anti-depressive Effect of Samul-tanggahyangbuja on Chronic Mild Stress in Ovariectomized Rats

3

조회

0

다운로드

5

인용

0

참고문헌

키워드

주제분류한의학

초록

Objectives: The purpose of the present study is to investigate anti-depressive effects of Samul-tanggahyangbuja (SGH) on ovariectomized and chronic mild stress (CMS) induced rats. Methods: Ovariectomized rats were exposed to CMS for 4 weeks. Changes of depression behavior were tested by using sucrose intake test (SIT), elevated plus maze (EPM), forced swimming test (FST) and Morris water maze test (MWMT) in rats until being orally medicated with SGH (100 or 400 mg/kg/day). In addition, the serum levels of corticosterone (CORT), IL-4, IL-1β and changes of 5-HT in the brain were measured. Results:1. SGH 400 mg/kg treated group (SGH 400) significantly increased amount of sucrose intake compared with the control group (p<0.05). 2. SGH 100 mg/kg treated group (SGH 100) and SGH 400 significantly increased the time spent in the open arms of the EPM compared with the control group (p<0.01). SGH 400 also significantly increased the number of crossing of the open and closed arms compared with the control group (p<0.05). 3. SGH significantly shortened the immobility time in FST compared with the control group (SGH 100 p<0.05, SGH 400 p<0.01). 4. SGH significantly increased performance of acquisition trials compared with the control group (p<0.05, on day 4, 5 of SGH 100 and 400). SGH 400 also significantly increased performance of retention trials compared with the control group (p<0.05). 5. The serum levels of corticosterone and IL-4 were not significantly different among the groups. There were no changes on the serum levels of corticosterone, IL-1β and IL-4 after administration with SGH. 6. SGH 400 significantly increased the level of 5-HT in the hippocampus compared with the control group (p<0.05). SGH significantly increased the levels of 5-HT in the hypothalamus compared with the control group (SGH 100 p<0.05, SGH 400 p<0.01). Conclusions: These results suggest that SGH has the anti-depressive effect on ovariectomized rat and affect 5-HT system rather than hypothalamic-pituitary -adrenal (HPA) axis and immune system.

Abstract

Objectives: The purpose of the present study is to investigate anti-depressive effects of Samul-tanggahyangbuja (SGH) on ovariectomized and chronic mild stress (CMS) induced rats. Methods: Ovariectomized rats were exposed to CMS for 4 weeks. Changes of depression behavior were tested by using sucrose intake test (SIT), elevated plus maze (EPM), forced swimming test (FST) and Morris water maze test (MWMT) in rats until being orally medicated with SGH (100 or 400 mg/kg/day). In addition, the serum levels of corticosterone (CORT), IL-4, IL-1β and changes of 5-HT in the brain were measured. Results:1. SGH 400 mg/kg treated group (SGH 400) significantly increased amount of sucrose intake compared with the control group (p<0.05). 2. SGH 100 mg/kg treated group (SGH 100) and SGH 400 significantly increased the time spent in the open arms of the EPM compared with the control group (p<0.01). SGH 400 also significantly increased the number of crossing of the open and closed arms compared with the control group (p<0.05). 3. SGH significantly shortened the immobility time in FST compared with the control group (SGH 100 p<0.05, SGH 400 p<0.01). 4. SGH significantly increased performance of acquisition trials compared with the control group (p<0.05, on day 4, 5 of SGH 100 and 400). SGH 400 also significantly increased performance of retention trials compared with the control group (p<0.05). 5. The serum levels of corticosterone and IL-4 were not significantly different among the groups. There were no changes on the serum levels of corticosterone, IL-1β and IL-4 after administration with SGH. 6. SGH 400 significantly increased the level of 5-HT in the hippocampus compared with the control group (p<0.05). SGH significantly increased the levels of 5-HT in the hypothalamus compared with the control group (SGH 100 p<0.05, SGH 400 p<0.01). Conclusions: These results suggest that SGH has the anti-depressive effect on ovariectomized rat and affect 5-HT system rather than hypothalamic-pituitary -adrenal (HPA) axis and immune system.

참고문헌 (50)

  1. Ballinger CB, "Psychiatric morbidity and the menopause: screening of general population sample", Br Med J, 3(5979), pp.344~346 (1975)
  2. Zweifel JE, "Meta-analysis of the effect of hormone replacement therapy upon depressed mood", Psychoneuroendocrinology, 22, pp.189~212 (1997)
  3. Oriental gynecology textbook complication committee, "Oriental gynecology", pp.221~248 (2002), Jeongdam
  4. Shin MK, "Clinical traditional herbalogy", pp.477~478 (1997), Youngrimsa
  5. Lee SI, "Tianjin prescription commentary", pp.53~60 (1987), Seougbosa
  6. Lee SY, "The effect of samul-tanggahyangbuja on depression and learning on repeated stress in ovariectomized rats", pp.2009
  7. Jang YJ, "The effect of samul-tanggahyangbuja on anti-depressive behavior and immunity", pp.2010
  8. Harro J, "Chronic mild unpredictable stress after noradrenergic denervation: attenuation of behavioural and biochemical effects of DPS-4 treatment", EUR. Neuropsychopharmacol, 10, pp.5~16 (1999)
  9. Pellow S, "Validation of open : closed arm entries in an elevated plusmaze as a measure of anxiety in the rat", J Neurosci Methods, 14(3), pp.149~167 (1985)
  10. Porsolt R, "Depression: a new animal model sensitive to antidepressant treatments", Nature, 266, pp.730~732 (1977)
  11. Cryan JF, "Assessing antidepressant activity rodents: recent developments and future needs", Trends Pharmacol Sci, 23(5), pp.238~245 (2002)
  12. Kessler RC, "Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the national comorbidity survey replication", Arch Gen Psychiatry, 2, pp.593~602 (2005)
  13. Weissman MM, "Depression: current understanding and changing trends", Annu Rev Public Health, 13, pp.319~339 (1992)
  14. Freeman EW, "Hormones and menopausal status as predictors of depression in women in transition to menopause", Arch Gen Psychiatry, 61, pp.62~70 (2004)
  15. Bromberger JT, "Racial", ethnic differences in the prevalence of depressive symptoms among middle-aged women: The study of women’s health across the nation(SWAN), 2004, pp.94, 1378~1385
  16. Cohen LS, "Risk for new onset of depression during the menopausal transition: the harvard study of moods and cycles", Arch Gen Psychiatry, 63, pp.385~390 (2006)
  17. Dennerstein L, "A population -based study of depressed mood in middle-aged, australian-born women", Menopause, 11, pp.563~568 (2004)
  18. Avis NE, "Longitudinal study of hormone levels and depression among women transitioning through menopause", Climacteric, 4, pp.243~249 (2001)
  19. Bosworth HB, "Depressive symptoms, menopausal status, and climacteric symptoms in women at midlife", Psychosom Med, 63, pp.603~608 (2001)
  20. American Psychiatric Association, "Diagnostic and statistical manual of mental disorder (DSM-IV)", pp.107~109 (1994), American Psychiatric Publishing, Inc
  21. Nowak G, "Antidepressant-like effects of acute and chronic treatment with zinc in forced swim test and olfactory bulbectomy model in rats", Brain Res, 61, pp.159~164 (2003)
  22. Oriental medicine Bangjehak classrooms, "Bangjehak", pp.287~288 (1999), Youngrimsa
  23. Park JH, "Effect of samul-tang on the biochemical changes in brain tissue of senile rat", pp.1998
  24. 김정환, "四物湯加葛根이 卵巢摘出로 誘發된 흰쥐의 骨多孔症에 미치는 영향", 한방재활의학과학회지, 17(4), pp.89~105 (2007), 한방재활의학과학회
  25. Chen SW, "Taepyeonghyeminhwajegukbang", pp.310~311 (1985), People's Health Publishers
  26. Cho BW, "Effects of a constituent herbs of samul-tang on antithrombosis and antistress", The Journal of Oriental Gynecology, 12(2), pp.41~74 (1999)
  27. Chen SW, "The effects of angelica essential oil in three murine tests of anxiety", Pharmacol Biochem Behav, 79(2), pp.377~382 (2004)
  28. Matsumoto K, "Effects of methylenechloride-soluble fraction of Japanese angelica root extract, ligustilide and butylidenephthalide on pentobarbital sleep in group-housed and socially isolated mice", Life Sci, 62(23), pp.2073~2082 (1998)
  29. 강지현, "천궁의 GABAA-benzodiazepine 수용체 복합체와의 상호작용", 생물치료정신의학, 3(2), pp.169~176 (1997), 대한생물치료정신의학회
  30. Liu TP, "Stimulatory effect of paeoniflorin on the release of noradrenaline from ileal synaptosomes of guinea-pig in-vitro", J Pharm Pharmacol, 54(5), pp.681~688 (2002)
  31. Kim SH, "Antidepressant effect of chaihu-shugan-san extract and its constituents in rat models of depression", 76(11), pp.1297~1306 (2005), Department of Neuropsychiatry. College of Medicine, Inje University
  32. Kim IJ, "Experimental study on the antidepressant effect of ginseng radix alba and cyperi rhizoma", J of Oriental Neuropsychiatry, 15(1), pp.101~119 (2004)
  33. Willner P, "Validity, reliability and utility of the chronic mild stress model of depression : a 10-year review and evaluation", Psychopharmacology, 134, pp.319~329 (1997)
  34. Willner P, "Chronic mild stress-induced anhedonia : a realistic animal model of depression", Neurosci Biobehav Rev, 16, pp.525~534 (1992)
  35. Anisman H, "Neurotransmitter, peptide and cytokine processes in relation to depressive disorder : comorbidity between depression and neurodegenerative disorders", Prog Neurobiol, 85(1), pp.1~74 (2008)
  36. De Kloet ER, "Stress and the brain : from adaptation to disease", Nat Rev Neurosci, 6, pp.463~475 (2005)
  37. Holsboer F, "The corticosteroid receptor hypothesis of depression", Neuropsychopharmacology, 23, pp.477~501 (2000)
  38. Linthorst AC, "Stress and the brain : solving the puzzle using microdialysis", Pharmacol Biochem Behav, 90, pp.163~173 (2008)
  39. McEwen BS, "Glucocorticoids, depression, and mood disorders : structural remodeling in the brain", Metabolism, 54, pp.20~23 (2005)
  40. Nemeroff CB, "The role of corticotropin-releasing factor in the pathogenesis of major depression", Pharmacopsychiatry, 21, pp.76~82 (1988)
  41. Sapolsky RM, "Stress and plasticity in the limbic system", Neurochem Res, 28, pp.1735~1742 (2003)
  42. Jang CG, "Nelumbinis semen reverses a decrease in 5-HT1A receptor binding induced by chronic mild stress, a depression-like", J Pharm Pharmacol, 27(10), pp.1065~1072 (2004)
  43. Willner P, "Reduction of sucrose preference by chronic unpredictable mild stress, and its restoration by a tricyclic antidepressant", Psychopharmacology, 93, pp.358~364 (1987)
  44. Rodgers RJ, "Anxiety, defense and the elevated plus-maze", Neurosci Behav Rev, 21, pp.801~810 (1997)
  45. Crabbe JC, "Genetics of mouse behavior : interactions with laboratory environment", Science, 284(5420), pp.1670~1672 (1999)
  46. Rudi D, "Application of the Morris water maze in the study of learning and memory", Brain Research Reviews, 36(1), pp.60~90 (2001)
  47. Jonathan R, "Diurnal variation of plasma corticosterone in depression", Psychoneuroendocrinology, 15(5-6), pp.485~488 (1990)
  48. Stamp J, "Corticosterone modulates autonomic responses and adaptation of central immediate-early gene expression to repeated restraint stress", Neuroscience, 107(3), pp.465~479 (2001)
  49. Sutcigil L, "Pro- and antiinflammatory cytokine balance in major depression: effect of sertraline therapy", Clinical and Developmental Immunology, pp.1~6 (2007)[DOI]
  50. Rho SH, "Advances on serotonin : implications for psychiatry", Wonkwang Psychiatry, 11(1), pp.3~26 (1995)

관련 논문AI추천

이 간행물의 다른 논문 (15건)